144 related articles for article (PubMed ID: 28759833)
1. Anti-oxidative treatment with vitamin E improves peripheral vascular function in patients with diabetes mellitus and Haptoglobin 2-2 genotype: A double-blinded cross-over study.
Alshiek JA; Dayan L; Asleh R; Blum S; Levy AP; Jacob G
Diabetes Res Clin Pract; 2017 Sep; 131():200-207. PubMed ID: 28759833
[TBL] [Abstract][Full Text] [Related]
2. Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes.
Hochberg I; Berinstein EM; Milman U; Shapira C; Levy AP
Curr Diab Rep; 2017 Jun; 17(6):42. PubMed ID: 28451949
[TBL] [Abstract][Full Text] [Related]
3. Impact of Vitamin E supplementation on vascular function in haptoglobin genotype stratified diabetes patients (EVAS Trial): a randomised controlled trial.
Dalan R; Goh LL; Lim CJ; Seneviratna A; Liew H; Seow CJ; Xia L; Chew DEK; Leow MKS; Boehm BO
Nutr Diabetes; 2020 Apr; 10(1):13. PubMed ID: 32341356
[TBL] [Abstract][Full Text] [Related]
4. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.
Milman U; Blum S; Shapira C; Aronson D; Miller-Lotan R; Anbinder Y; Alshiek J; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):341-7. PubMed ID: 18032779
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.
Costacou T; Levy AP; Miller RG; Snell-Bergeon J; Asleh R; Farbstein D; Fickley CE; Pambianco G; de la Vega R; Evans RW; Orchard TJ
Acta Diabetol; 2016 Apr; 53(2):243-50. PubMed ID: 26002590
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.
Nakhoul FM; Miller-Lotan R; Awad H; Asleh R; Jad K; Nakhoul N; Asaf R; Abu-Saleh N; Levy AP
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F830-8. PubMed ID: 19176700
[TBL] [Abstract][Full Text] [Related]
7. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
Dalan R; Liuh Ling G
Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype.
Farbstein D; Blum S; Pollak M; Asaf R; Viener HL; Lache O; Asleh R; Miller-Lotan R; Barkay I; Star M; Schwartz A; Kalet-Littman S; Ozeri D; Vaya J; Tavori H; Vardi M; Laor A; Bucher SE; Anbinder Y; Moskovich D; Abbas N; Perry N; Levy Y; Levy AP
Atherosclerosis; 2011 Nov; 219(1):240-4. PubMed ID: 21722898
[TBL] [Abstract][Full Text] [Related]
9. Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?
Vardi M; Levy AP
Curr Diab Rep; 2012 Jun; 12(3):274-9. PubMed ID: 22427005
[TBL] [Abstract][Full Text] [Related]
10. Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.
Asleh R; Blum S; Kalet-Litman S; Alshiek J; Miller-Lotan R; Asaf R; Rock W; Aviram M; Milman U; Shapira C; Abassi Z; Levy AP
Diabetes; 2008 Oct; 57(10):2794-800. PubMed ID: 18599520
[TBL] [Abstract][Full Text] [Related]
11. Patient selection and vitamin E treatment in diabetes mellitus.
Goldenstein H; Levy NS; Lipener YT; Levy AP
Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):319-26. PubMed ID: 23469912
[TBL] [Abstract][Full Text] [Related]
12. Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype.
Blum S; Vardi M; Brown JB; Russell A; Milman U; Shapira C; Levy NS; Miller-Lotan R; Asleh R; Levy AP
Pharmacogenomics; 2010 May; 11(5):675-84. PubMed ID: 20415560
[TBL] [Abstract][Full Text] [Related]
13. Antioxidants in the prevention of atherosclerosis: the importance of proper patient selection.
Levy Y; Blum S; Levy AP
Clin Nutr; 2009 Oct; 28(5):581-2. PubMed ID: 19464773
[TBL] [Abstract][Full Text] [Related]
14. Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.
Vardi M; Blum S; Levy AP
Eur J Intern Med; 2012 Oct; 23(7):628-32. PubMed ID: 22939808
[TBL] [Abstract][Full Text] [Related]
15. The Role of Haptoglobin Polymorphism in Cardiovascular Disease in the Setting of Diabetes.
Somer S; Levy AP
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396615
[TBL] [Abstract][Full Text] [Related]
16. Haptoglobin: basic and clinical aspects.
Levy AP; Asleh R; Blum S; Levy NS; Miller-Lotan R; Kalet-Litman S; Anbinder Y; Lache O; Nakhoul FM; Asaf R; Farbstein D; Pollak M; Soloveichik YZ; Strauss M; Alshiek J; Livshits A; Schwartz A; Awad H; Jad K; Goldenstein H
Antioxid Redox Signal; 2010 Feb; 12(2):293-304. PubMed ID: 19659435
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E.
Levy AP; Blum S
Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1105-11. PubMed ID: 18035926
[TBL] [Abstract][Full Text] [Related]
18. The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women.
Levy AP; Friedenberg P; Lotan R; Ouyang P; Tripputi M; Higginson L; Cobb FR; Tardif JC; Bittner V; Howard BV
Diabetes Care; 2004 Apr; 27(4):925-30. PubMed ID: 15047650
[TBL] [Abstract][Full Text] [Related]
19. Haptoglobin Genotype Is a Determinant of Hemoglobin Adducts and Vitamin E Content in HDL.
Goldenstein H; Levy NS; Ward J; Costacou T; Levy AP
J Diabetes Res; 2018; 2018():6125420. PubMed ID: 29888289
[TBL] [Abstract][Full Text] [Related]
20. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Ward NC; Wu JH; Clarke MW; Puddey IB; Burke V; Croft KD; Hodgson JM
J Hypertens; 2007 Jan; 25(1):227-34. PubMed ID: 17143195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
